Pilot Study With Peginterferon, Ribavirin, and Boceprevir Prior to Transplantation to Clear Virus in Hepatitis C Genotype 1 Infected Individuals Undergoing Orthotopic Liver Transplantation
Phase of Trial: Phase 0
Latest Information Update: 09 May 2019
Price : $35 *
At a glance
- Drugs Boceprevir (Primary) ; Peginterferon; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors Merck & Co
- 23 Jul 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 01 Aug 2013 New trial record
- 01 Jun 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.